Profile data is unavailable for this security.
About the company
P3 Health Partners Inc. is a patient-centered and physician-led population health management company. The Company supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, it creates an enhanced patient experience by navigating, coordinating, and integrating the patient’s care within the healthcare system. Its technology platform, P3 Technology/Health Hub, enables physicians, care teams, patients and their family members to engage in the care journey. P3 Technology/Health Hub integrates clinical and claims data from more than 250 disparate data points each month from payors, outpatient and inpatient facilities and other ancillary care settings. It has a network of more than 2,800 affiliated primary care providers across the country. Its local teams of health care professionals manage the care of thousands of patients in 23 counties across five states.
- Revenue in USD (TTM)1.35bn
- Net income in USD-67.27m
- Incorporated2020
- Employees400.00
- LocationP3 Health Partners Inc2045 W Grand Ave Ste B, Pmb # 82152CHICAGO 60612-1577United StatesUSA
- Phone+1 (312) 822-8897
- Fax+1 (302) 636-5454
- Websitehttps://ir.p3hp.org/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Context Therapeutics Inc | 0.00 | -21.32m | 148.50m | 5.00 | -- | 3.74 | -- | -- | -1.34 | -1.34 | 0.00 | 0.5288 | 0.00 | -- | -- | 0.00 | -99.14 | -- | -114.72 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -61.53 | -- | -- | -- |
| Regulus Therapeutics Inc | 0.00 | -31.37m | 149.92m | 28.00 | -- | 1.39 | -- | -- | -1.46 | -1.46 | 0.00 | 1.64 | 0.00 | -- | -- | 0.00 | -41.50 | -53.74 | -45.91 | -76.96 | -- | -- | -- | -715.58 | -- | -- | 0.005 | -- | -- | -- | -6.05 | -- | 94.54 | -- |
| Mediwound Ltd | 19.85m | -12.75m | 151.42m | 100.00 | -- | 6.67 | -- | 7.63 | -1.38 | -1.38 | 2.15 | 2.44 | 0.303 | 5.64 | 5.07 | 198,510.00 | -19.46 | -24.48 | -25.65 | -32.92 | 16.92 | 43.27 | -64.24 | -38.43 | 1.83 | -- | 0.218 | -- | -29.48 | 40.60 | 65.73 | -- | 64.66 | -- |
| Seres Therapeutics Inc | 126.85m | -82.68m | 151.45m | 233.00 | -- | -- | -- | 1.19 | -0.6062 | -0.6062 | 0.9495 | -0.3945 | 0.4149 | -- | -- | 544,407.80 | -27.04 | -41.51 | -36.82 | -54.13 | -- | -- | -65.18 | -170.14 | 1.25 | -9.21 | 2.41 | -- | 1,672.24 | 34.91 | 54.54 | -- | 32.72 | -- |
| CervoMed Inc | 8.08m | -4.15m | 156.33m | 8.00 | 37.05 | 21.90 | -- | 19.34 | 0.5113 | 0.5113 | 1.74 | 0.8648 | 0.6124 | -- | -- | 1,010,531.00 | -31.45 | -53.67 | -38.42 | -58.89 | -- | -- | -51.36 | -949.54 | -- | -- | 0.00 | -- | -- | -- | 86.07 | -- | -- | -- |
| OptiNose Inc | 74.02m | -30.75m | 156.43m | 132.00 | -- | -- | -- | 2.11 | -0.2733 | -0.2733 | 0.659 | -0.8777 | 0.7453 | 0.8764 | 4.74 | 560,772.80 | -30.91 | -48.25 | -- | -98.95 | 88.98 | 86.96 | -41.47 | -131.66 | 2.17 | -1.16 | 4.16 | -- | -6.93 | 58.64 | 52.58 | -- | -27.96 | -- |
| CytoDyn Inc | 0.00 | -51.69m | 156.71m | 12.00 | -- | -- | -- | -- | -0.055 | -0.055 | 0.00 | -0.1206 | 0.00 | -- | -- | 0.00 | -414.98 | -259.98 | -- | -- | -- | -- | -- | -235,303.80 | -- | -0.88 | -- | -- | -100.00 | -- | 62.14 | -- | -- | -- |
| ProQR Therapeutics NV | 14.62m | -29.10m | 158.64m | 157.00 | -- | 4.35 | -- | 10.85 | -0.3584 | -0.3584 | 0.1801 | 0.4481 | 0.0957 | -- | -- | 93,136.34 | -18.83 | -35.51 | -23.01 | -40.51 | -- | -- | -196.75 | -926.31 | -- | -- | 0.3557 | -- | 118.51 | 10.58 | 56.35 | -- | 34.45 | -- |
| P3 Health Partners Inc | 1.35bn | -67.27m | 158.69m | 400.00 | -- | 0.4089 | -- | 0.1173 | -0.5855 | -0.5855 | 11.86 | 1.23 | 1.57 | -- | 11.40 | 3,381,965.00 | -21.31 | -- | -90.11 | -- | 1.59 | 0.1781 | -13.57 | -56.93 | -- | -10.05 | 0.2368 | -- | 20.67 | 70.58 | 78.61 | -- | -11.20 | -- |
| Alimera Sciences Inc | 90.22m | -22.66m | 159.79m | 159.00 | -- | 3.93 | -- | 1.77 | -1.57 | -1.57 | 2.42 | 0.7762 | 0.8989 | 7.11 | 3.43 | 567,415.10 | -21.34 | -19.08 | -25.84 | -27.37 | 86.52 | 86.80 | -23.74 | -19.55 | 2.51 | -0.0756 | 0.6323 | -- | 49.19 | 11.62 | -18.14 | -- | 236.53 | -- |
| Rezolute Inc | 0.00 | -58.21m | 161.74m | 51.00 | -- | 2.28 | -- | -- | -1.14 | -1.14 | 0.00 | 1.77 | 0.00 | -- | -- | 0.00 | -52.46 | -58.48 | -55.28 | -63.38 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -26.13 | -- | 92.29 | -- |
| Atossa Therapeutics Inc | 0.00 | -29.69m | 163.48m | 10.00 | -- | 1.90 | -- | -- | -0.2359 | -0.2359 | 0.00 | 0.6833 | 0.00 | -- | -- | 0.00 | -28.65 | -29.97 | -29.84 | -32.55 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -11.62 | -- | -33.90 | -- |
| Adverum Biotechnologies Inc | 0.00 | -112.90m | 164.39m | 121.00 | -- | 0.9018 | -- | -- | -10.23 | -10.23 | 0.00 | 8.78 | 0.00 | -- | -- | 0.00 | -41.55 | -36.39 | -47.50 | -39.04 | -- | -- | -- | -5,279.60 | -- | -- | 0.00 | -- | -- | 17.43 | 24.18 | -- | -0.0247 | -- |
| Outlook Therapeutics Inc | 0.00 | -159.13m | 165.48m | 24.00 | -- | -- | -- | -- | -11.48 | -11.48 | 0.00 | -6.10 | 0.00 | -- | -- | 0.00 | -281.52 | -214.69 | -2,060.72 | -1,843.48 | -- | -- | -- | -3,043.92 | -- | -26.75 | -- | -- | -- | -- | 10.70 | -- | -- | -- |
| Kodiak Sciences Inc | 0.00 | -232.75m | 167.06m | 107.00 | -- | 0.6925 | -- | -- | -4.44 | -4.44 | 0.00 | 4.59 | 0.00 | -- | -- | 0.00 | -43.30 | -31.73 | -47.44 | -33.61 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 21.97 | -- | 134.76 | -- |
Data as of Jun 03 2024. Currency figures normalised to P3 Health Partners Inc's reporting currency: US Dollar USD
14.18%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Columbia Wanger Asset Management LLCas of 31 Mar 2024 | 7.51m | 6.29% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 2.24m | 1.88% |
| Janus Henderson Investors US LLCas of 31 Mar 2024 | 2.12m | 1.78% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 1.44m | 1.20% |
| EMFO LLCas of 31 Mar 2024 | 1.02m | 0.86% |
| Geode Capital Management LLCas of 31 Mar 2024 | 909.48k | 0.76% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 677.13k | 0.57% |
| GSA Capital Partners LLPas of 31 Mar 2024 | 565.52k | 0.47% |
| Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 2024 | 304.77k | 0.26% |
| Squarepoint OPS LLCas of 31 Mar 2024 | 143.76k | 0.12% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
